Naltrexone Effects on Alcohol Intake

Naltrexone Effects on Alcohol Intake Using a Laboratory Bar in Asp40 Positive and Negative Alcohol Users Characterized by fMRI and Genetic Screening

NCT00254670•University of California, San Francisco

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Social Drinker

Interventions

Naltrexone

Locations

United States

Locations (1)

UCSF

San Francisco, California, United States

Key Dates

Start Date

February 1, 2005

Primary Completion Date

December 1, 2005

Completion Date

December 1, 2006

Last Updated

May 8, 2023

Sponsors

Lead Sponsor

University of California, San Francisco

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 8, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions